Edge Rewrite
// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a287fda6e9c53f27

Jump to content

Betamipron

From Wikipedia, the free encyclopedia

Betamipron
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 3-(benzoylamino)propanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC10H11NO3
Molar mass193.202 g·mol−1
3D model (JSmol)
Melting point120 °C (248 °F)
  • O=C(NCCC(=O)O)c1ccccc1
  • InChI=1S/C10H11NO3/c12-9(13)6-7-11-10(14)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,14)(H,12,13) checkY
  • Key:CWXYHOHYCJXYFQ-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Betamipron (INN) or N-benzoyl-β-alanine is a chemical adjunct which is used together with panipenem[1] in the formulation sold as Carbenin to inhibit panipenem uptake into the renal tubule and prevent nephrotoxicity.[2] Alone it has no antibacterial function.[3]

See also

[edit]

References

[edit]
  1. Finch RG (2003). Antibiotic and chemotherapy: anti-infective agents and their use in therapy. Elsevier Health Sciences. pp. 269–. ISBN 978-0-443-07129-4. Retrieved 8 August 2011.
  2. Goa KL, Noble S (2003). "Panipenem/betamipron". Drugs. 63 (9): 913–25, discussion 926. doi:10.2165/00003495-200363090-00005. PMID 12678575. S2CID 263994230.
  3. Ohashi N, Uematsu T, Nagashima S, Kanamaru M, Tajima N, Togawa A, et al. (February 2005). "Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease". Journal of Infection and Chemotherapy. 11 (1): 24–31. doi:10.1007/s10156-004-0359-6. PMID 15729484.